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Abstract 
Objectives: To describe the audiologic phenotype in osteogenesis imperfecta (OI). 
Study design: Observational study. 
Setting: Tertiary referral center. 
Patients: One hundred eighty-two patients with genetically confirmed OI, aged 3 to 89 years.  
Intervention: Diagnostic hearing evaluation through otoadmittance and acoustic stapedius reflex 
measurements, pure tone, and speech audiometry. 
Main outcome measure(s): Prevalence, type, severity, symmetry, and audiometric configuration of 
the hearing loss in OI. Progression of hearing thresholds was determined by constructing age-related 
typical audiograms. 
Results: Approximately 52.2% of all OI patients demonstrated hearing loss unilaterally (7.7%) or 
bilaterally (44.5%). Pure conductive, mixed and pure sensorineural hearing losses were observed in 
8.5%, 37.8% and 11.6% of OI ears, respectively. Multiple linear regression revealed that thresholds 
progressed by 0.5 dB/year at 0.25 kHz to 0.8 dB/year at 0.8 kHz in the ears with conductive or mixed 
hearing loss. Pure sensorineural hearing loss progressed by less than 0.1 dB/year at 0.25 kHz to 1.2 
dB/year at 8.0 kHz. Audiometric configuration was predominantly flat (70.5%) in the ears with 
conductive/mixed loss, and sloping (50.0%) in those with pure sensorineural loss.   
Conclusions: Patients with OI are at risk for hearing loss. The hearing loss in OI may initiate at a 
young age and is progressive. However, the rate of progression, as well as the hearing loss severity, 
onset and configuration depend on the type of hearing loss, which may be conductive/mixed or pure 
sensorineural. For both types, age-related threshold audiograms are constructed and may help the 
clinician to estimate the course of the hearing loss in patients with OI. In addition, they may be 
valuable to distinguish between hearing loss associated with OI and other similar forms of hearing 
loss, such as in otosclerosis. 
Key words: Osteogenesis imperfecta; hearing loss; age-related typical audiogram.  
  
1. Introduction 
Osteogenesis imperfecta (OI) is a rare generalized connective tissue disorder caused by a 
heterozygous mutation in the gene COL1A1 or COL1A2. Both genes encode for type I (pro)collagen, 
an important protein in the extracellular matrix of bone, skin, sclerae, blood vessels, and tendons. The 
disease is clinically characterized by a high rate of bone fractures, which may occur spontaneously or 
after minor trauma, by blue sclerae, abnormal dentine, and hearing loss. 
Sillence et al.
1
 proposed a classification in which a mild (Type I), a lethal (Type II), a severe (Type III) 
and a moderate-to-severe (Type IV) phenotype are distinguished. The disease is inherited in an 
autosomal dominant manner, but, recently, identification of mutations in other, autosomal recessive, 
genes has resulted in addition of Types V to XI
2-4
. These novel types count for only 5% of all OI 
patients and have not been associated with hearing loss up to now
2
, while about half of the OI patients 
with mutations in COL1A1 and COL1A2 are hearing impaired
5-12
. In adolescence or young adulthood, 
most often, a conductive hearing loss develops. It may be attributed to an otosclerosis-like focus of 
abnormal bone remodeling affecting the oval window region and causing stapes footplate fixation. In 
comparison with otosclerosis, the hearing loss in OI is characterized by an earlier onset and more 
often progresses to a mixed hearing loss in which the pericochlear involvement is more severe and 
extensive
5-12
. Stapes surgery has been proven to be an efficient technique to reduce the conductive 
component of the hearing loss in OI
13-17
. Thickened, irregular and hard footplates as well as brittle and 
soft footplates have been described. In addition, stapes crura may be atrophic or fractured. 
Postmortem histopathological examination of the temporal bones originating from a number of adult OI 
patients who had developed mixed hearing loss confirmed the presence of vascular and otosclerotic 
changes encroaching on the stapes footplate and entailing stapes ankylosis, which could involve 
cochlear and vestibular parts of the otic capsule as well
18-21
. Furthermore, thinning of the cortical 
layers of the otic capsule and the ossicles were observed. The ossicles may show marked porosity 
and fractures, and may contain an extensive number of spaces for vessels and soft tissue.  
In a minority of the OI patients, a pure sensorineural hearing loss develops.  
Hearing loss of either type is progressive in OI, but rarely ends up in total deafness
5, 8, 10
. In case of 
severe bilateral hearing loss with a substantial sensorineural component, cochlear implantation may 
offer a last solution. Though, patients should be well selected and inner ear architecture well evaluated 
preoperatively as the disease implies a higher risk on complicated electrode insertion and on 
 
 
unwanted secondary stimulation effects. The latter is possibly due to reduced impedance to current 
spread in abnormal bone tissue
22-24
. 
In an attempt to link the hearing loss to the underlying OI genotype, no correlation was found between 
the development or the type of hearing loss and the mutated gene, being COL1A1 or COL1A2, or the 
type of the mutation
25
.  
On the basis of an extensive audiometric examination in a large cohort of OI patients, the audiologic 
phenotype of the hearing loss associated with OI is presented. Age-related thresholds audiograms 
(ARTAs) are constructed to visualize the progression of hearing loss in OI and to provide age-related 
reference thresholds, which may be useful for clinicians concerned with this disease. Determination of 
ARTAs in OI has, to our knowledge, never been attempted before, probably because the underlying 
OI genotype was not systematically investigated in all patients. 
 
2. Methods 
2.1. Subjects 
In a large study investigating a correlation between OI-related hearing loss and the underlying OI 
genotype, a cohort of Belgian, Dutch and Italian OI patients underwent audiologic evaluation at the 
departments of otorhinolaryngology from the Ghent University Hospital, the Radboud University 
Nijmegen Medical Center and at the pediatric department of the La Sapienza University of Rome. After 
exclusion of the patients with suspicion of hearing loss due to causes other than OI, such as otitis 
media and noise exposure, audiometric characteristics from 182 OI subjects (84 Belgian; 67 Dutch; 31 
Italian) or 364 ears were analyzed. In case of previous middle ear surgery or cochlear implantation, 
the preoperative audiometric data were retrieved and included for analysis. The mean age of the 
patients (88 males; 94 females) at audiometric evaluation was 30.2 years (SD: 16.9; range: 3-89 
years). 
All subjects were identified with a mutation in either the COL1A1 (n=149) or the COL1A2 (n=33) gene 
and were clinically diagnosed as OI Type I (n=152), Type III (n=4) or Type IV (n=26). 
  
  
  
2.2. Micro-otoscopy and audiologic evaluation 
After micro-otoscopic examination of the ear by an experienced otologist, hearing was evaluated 
through otoadmittance and acoustic stapedius reflex (ASR) measurements, as well as pure tone and 
speech audiometry. 
 
2.2.1. Otoadmittance and ASR measurements 
Tympanograms and two-component admittance measurements were obtained bilaterally using an 85-
dB SPL 226- and 678-Hz probe tone, respectively, and ipsi- and contralateral ASR thresholds were 
determined for 0.5, 1.0, 2.0 kHz, and broadband noise stimuli (TympStar, Grason Stadler Inc., MN, 
USA).  The 678-Hz probe tone was not used in the evaluation of the Italian patients. Tympanograms at 
226 Hz were classified according to types (A, As, Ad, B, and C) as described by Jerger
26
. The criteria 
elaborated by Vanhuyse et al.
27
 were applied to classify 678 two-components admittance 
tympanograms into ears at resonance, mass controlled and stiffness controlled ears, and to decide 
whether they deviated from normal. 
 
2.2.2. Pure-tone audiometry 
Pure-tone and speech audiometry were performed in a double-walled sound-attenuated room. 
Applying the modified Hughson-Westlake method, air conduction (AC) thresholds were bilaterally 
determined at octave frequencies of 0.25 to 8.0 kHz and at half-octave frequencies of 3.0 and 6.0 kHz, 
as well as bone conduction (BC) thresholds at octave-frequencies of 0.25 to 4.0 kHz and half-octave 
frequency 3.0 kHz (AC 40 Clinical Audiometer, Interacoustics, Assens, Denmark). Masking noise was 
presented at the contralateral ear through a headphone to assess masked AC and BC thresholds 
according to Hood’s plateau method, when interaural differences in AC or intra-aural air-bone gap 
(ABG) were beyond 40 and 10 dB, respectively. Pure tone average (PTA) was calculated for AC and 
BC on the basis of the thresholds at 0.5, 1.0 and 2.0 kHz. 
Hearing loss was classified as (1) conductive: PTA (BC) < 15 dB HL and ABG ≥ 15 dB averaged over 
0.5, 1.0 and 2.0 kHz; (2) pure sensorineural: PTA (AC) ≥ 15 dB HL and ABG < 15 dB averaged over 
0.5, 1.0 and 2.0 kHz; (3) high-frequency sensorineural: AC thresholds > 30 dB HL averaged over 4.0, 
6.0 and 8.0 kHz; and (4) mixed: PTA (BC) ≥ 15 dB HL and ABG ≥ 15 dB averaged over 0.5, 1.0 and 
 
 
2.0 kHz. Hearing loss was substantiated by comparison with the 95
th
 percentile value for gender- and 
age-related hearing thresholds
28
.  
The severity of the hearing loss was established as mild [15 dB HL ≤ PTA (AC) < 40 dB HL], moderate 
[40 dB HL ≤ PTA (AC) ˂ 70 dB HL], severe [70 dB HL ≤ PTA (AC) ˂ 95 dB HL] or profound [95 dB HL 
≤ PTA (AC)] hearing loss. Audiometric configuration was determined, and according to Schlaugh & 
Nelson
29
, classified into flat, gradually falling (5 to 12 dB rise or fall per octave), sharply falling (15 to 
20 dB increase per octave), precipitously falling (flat or gradually sloping, then threshold increase of 25 
dB or more per octave), peaked or saucer (20 dB or greater loss at the extreme frequencies but not at 
1.0 and 2.0 kHz), trough (20 dB or greater loss at 1.0 and 2.0 kHz, but not at the extreme frequencies) 
or notched (20 dB or greater loss at one frequency with complete recovery at the adjacent 
frequencies) audiograms. 
Asymmetric hearing loss was defined as more than 10 dB difference between the ears for at least two 
frequencies with a difference in PTA between the ears of more than 20 dB. 
 
2.2.3. Speech audiometry 
Speech audiometry was performed in all Dutch and Belgian patients over 5 years of age (n=114). A 
Dutch monosyllabic wordlist was presented monaurally under headphone with contralateral masking 
noise if appropriate to determine the speech reception threshold (SRT) and the maximal perception 
percentage.  
 
2.3. Statistical analysis 
All mathematical computations and statistical processing were performed using SPSS, software 
version 15.0 (SPSS Inc., Chicago, IL, USA). The normal distribution of quantitative variables was 
evaluated by the Kolmogorov-Smirnov test. In the group of patients with hearing loss, progression of 
the hearing impairment was analyzed at each frequency by multiple linear regression analysis, with 
age, sex, and mutated gene (COL1A1 or COL1A2) as independent variables and the hearing 
threshold as outcome variable. At each frequency, different regression equations were obtained for AC 
and BC. The regression coëfficient for age represents the frequency-specific annual threshold 
deterioration (ATD) expressed in decibels per year. Hence, ARTAs at ages 10, 20, 30, 40, 50, and 60 
years were constructed.  
  
3. Results 
3.1. Micro-otoscopic examination 
Micro-otoscopy revealed normal eardrums in 52.2% of all the evaluated OI ears (N=364). Translucent 
eardrums were found in 42.3% of OI ears and 5.5% exhibited signs of atrophic scarring or 
tympanosclerosis. 
 
3.2. Audiometric evaluation 
3.2.1. Prevalence and type of hearing loss 
In 52.2% of the OI patients hearing was impaired unilaterally (7.7%) or bilaterally (44.5%), providing a 
47.8% prevalence of hearing impairment in the total number of 364 OI ears. The different types of 
hearing loss diagnosed in these ears are summarized in Table 1. A mixed hearing loss was the most 
frequently observed hearing loss type. In five ears with total deafness, retrieval of audiometric history 
revealed that mixed hearing loss had preceded the deafness in all cases.  
 
Table 1. Prevalence and types of hearing loss in 364 osteogenesis 
imperfecta ears. 
Hearing phenotype No. of ears (%) 
Normal hearing 190 (52.2) 
Pure conductive hearing loss 31 (8.5) 
Mixed hearing loss 96 (26.4) 
Pure sensorineural hearing loss 37 (10.2) 
High-frequency sensorineural hearing loss 5 (1.4) 
Deafness 5 (1.4) 
 
In Figure 1 the prevalence and types of hearing loss are presented as a function of age, the latter 
classified into seven distinct age categories. The ears presenting total deafness and the ears with 
high-frequency sensorineural hearing loss were included in the groups of mixed and pure 
sensorineural hearing loss, respectively. Pure conductive loss was present in a minority of patients, all 
from the younger age groups, whereas mixed and pure sensorineural losses were observed more 
frequently and at all ages. The proportion of patients with hearing impairment increased till the fourth 
decade, after which it remained relatively stable. Our male and female OI population did not differ in 
the prevalence or type of hearing loss. 
 
 
 
 
Figure 1 Prevalence and type of hearing loss in different age categories of patients with 
osteogenesis imperfecta. 
The vertical bars represent the percentage of hearing impaired ears in seven different age 
categories of patients with osteogenesis imperfecta. A color code is applied for distinction 
between conductive (C HL), mixed (M HL) and pure sensorineural hearing loss (SNHL). 
 
3.2.2. Hearing loss onset 
In the analysis of the subjective onset of the hearing loss in OI, the pure conductive and mixed hearing 
losses were pooled because conductive hearing loss in OI usually evolves to a mixed hearing loss 
with time and an identical underlying pathology is assumed. The onset of conductive/mixed hearing 
loss was mainly situated in the second to fourth decades of life with a mean age at onset of 21.3 years 
(SD: 9.7; range: 5-42 years). Pure sensorineural hearing loss was reported to have developed at any 
age with a mean onset age of 30.2 years (SD: 14.3; range: 10-50 years).   
 
3.2.3. Severity of hearing loss  
The hearing loss severity varied with age and with the type of hearing loss. Pure sensorineural losses 
were mainly (95.2%) mild (15-40 dB HL), and in a few cases (4.8%), moderate (40-75 dB HL). The 
conductive/mixed hearing losses were mild to moderate in the younger age groups and varied from 
mild to profound (>95 dB HL) in the age categories above 40 years of age. However, one ear in the 
age category 10 to 19 years showed a severe mixed hearing loss.   
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3.2.4. Audiometric configuration 
Most of the conductive/mixed hearing losses were characterized by a flat audiogram (70.5%), followed 
by gradually falling (16.6%), precipitously falling (9.1%), rising (2.3%) and sharply falling audiograms 
(1.5%). Pure sensorineural losses most often showed a sloping audiogram (50.0%), which was 
precipitously falling in 33.3% and gradually falling in 16.7%. Still, a considerable part of sensorineural 
losses had a flat audiogram (45.2%). One patient with pure sensorineural hearing loss demonstrated 
an atypical trough audiogram bilaterally.   
 
3.2.5. Symmetry of hearing loss 
All patients demonstrating bilateral hearing loss had identical hearing loss types in both ears, except 6 
patients who demonstrated a conductive or mixed hearing loss in the one, and a pure sensorineural 
hearing loss in the other ear. Furthermore, 8 and 6 patients showed unilateral conductive or mixed and 
unilateral pure sensorineural hearing loss, respectively. In 17.3% of the patients with bilateral hearing 
loss, the recorded audiograms for left and right ears were asymmetric. 
 
3.2.6. ARTA 
Mutiple linear regression was carried out on each frequency to construct ARTAs at ages 10, 20, 30, 
40, 50 and 60 years for conductive evolving to mixed hearing loss and for pure sensorineural hearing 
loss, separately. The analysis revealed no effect of the mutated gene on the progression of the 
hearing thresholds in patients with conductive/mixed hearing loss nor in those with pure sensorineural 
loss, enabling us to join patients with COL1A1 and COL1A2 mutations together in further calculations. 
In contrast, sex significantly (P<0.05) determined the progression of the thresholds in the instance of 
pure sensorineural hearing loss but not in the conductive/mixed hearing losses. Therefore, distinct 
ARTAs are created for female and male patients with pure sensorineural loss. Figure 2 displays the 
ARTAs for AC and BC for OI patients developing hearing loss characterized by a conductive 
component. Linear regression on the ABG revealed no dependency of age at any frequency. One-way 
analysis of variance with frequency as independent variable and ABG as outcome variable yielded 
that ABG was frequency-specific (P<0.001) exhibiting the largest values at the lowest frequencies. 
The hearing loss is progressive at all frequencies, with an ATD averaged over the frequencies 0.5, 1.0, 
and 2.0 kHz of 0.6 dB/year for AC and 0.4 dB/year for BC, respectively. ATD is most prominent at the 
 
 
highest frequencies, attaining 0.9 dB/year and 0.8 dB/year for AC thresholds at 4.0 and 8.0 kHz, 
respectively.  
The ARTAs reflecting the AC thresholds in male and female OI patients with pure sensorineural loss 
are given in Figure 3. The average ATD over the frequencies 0.5, 1.0, and 2.0 kHz was 0.2 dB/year, 
whereas at 4.0 and 8.0 kHz the ATD mounted to 0.9 dB/year and 1.2 dB/year, respectively. 
 
Figure 2. Age-related thresholds audiograms for osteogenesis imperfecta patients 
developing conductive/mixed hearing loss 
Six different audiograms represent the average audiometric air conduction (AC) and 
bone conduction (BC) thresholds of patients with osteogenesis imperfecta developing 
hearing loss of the conductive/mixed type at ages 10, 20, 30, 40, 50, and 60 years. Age-
related air conduction thresholds corresponding to the 95
th
 percentile in the healthy adult 
female [P95 ISO (F)] and male [P95 ISO (M)] population are indicated on the 
audiograms. 
 
  
 
Figure 3. Age-related thresholds audiograms for osteogenesis imperfecta patients with 
pure sensorineural hearing loss  
Six different audiograms represent the average air conduction (AC) thresholds in female 
(F) and male (M) osteogenesis imperfecta patients affected by pure sensorineural hearing 
loss at ages 10, 20, 30, 40, 50 and 60 years. Age-related air conduction thresholds 
corresponding to the 95
th
 percentile in the healthy adult female [P95 ISO (F)] and male 
[P95 ISO (M)] population are indicated on the audiograms.  
 
 
3.3. Speech audiometry 
The SRT fitted into the expected 10-dB range around the PTA calculated from AC thresholds at 0.5, 
1.0 and 2.0 kHz in 86.0% of the hearing-impaired ears. An SRT surpassing this PTA by more than 10 
dB was recorded in 21.2% of the ears with a conductive/mixed and in 9.4% of those with a pure 
sensorineural hearing loss.  
 
 
 
3.4. Acoustic admittance measurements 
 The tympanometric shape obtained at 226 Hz did not correspond to the type of the hearing loss, 
because tympanograms of types A, As and Ad tympanograms were registered to the same proportions 
in ears with normal, conductive, mixed, and sensorineural hearing loss (Table 2). Neither static 
acoustic admittance values nor the observation of type Ad tympanograms were associated with thin, 
translucent eardrums at micro-otoscopy. In ears with translucent eardrums, we found type A (77.8%) 
as well as Ad (13.0%) and As (9.3%) tympanograms. 
 
Table 2. Tympanometric shapes (226 Hz) with regard to the hearing loss type. 
Tympanometric shape Normal Conductive/mixed 
hearing loss 
Pure sensorineural 
hearing loss 
 (n=189) (n=65) (n=42) 
Type A, No. of ears (%) 143 (75.7) 43 (66.2) 30 (71.4) 
Type As, No. of ears (%) 24 (12.7) 10 (15.4) 6 (14.3) 
Type Ad, No. of ears (%) 22 (11.6) 12 (18.4) 6 (14.3) 
Terminology of the tympanometric shapes corresponds to the classification proposed by 
Jerger (1970)
26
 
 
Two-component admittance measurements yielded normal results in 93.3% of ears with normal 
hearing, in 90.4% of ears with a conductive hearing loss component, and in 91.7% of the ears with a 
pure sensorineural loss.  
 
3.5. ASR measurements 
Ipsilateral and contralateral ASRs were elicitable at each of the four stimuli in 79.4% and in 67.7%, 
respectively, of the ears demonstrating normal hearing, whereas ipsilateral and contralateral ASRs 
were completely absent in all ears with conductive and mixed hearing losses. In the ears with pure 
sensorineural loss, ipsilateral and contralateral ASRs were absent in 40.5% and 45.2%, respectively. 
All normal-hearing ears with totally absent ASRs belonged to patients younger than 30 years. 
 
4. Discussion 
A considerable proportion of OI patients develop hearing loss, which manifests most often bilaterally 
and affects male and female patients to the same proportion. It may be either a conductive hearing 
loss that evolves to a mixed hearing loss, or a pure sensorineural hearing loss. Compared to pure 
sensorineural loss, conductive/mixed hearing loss in OI is more prevalent and is characterized by an 
  
earlier onset and more severe progression. The age-related typical audiograms for both hearing loss 
types reflect these differences and may serve as a useful reference tool for otologists encountering 
patients with OI. 
Although the prevalence of hearing loss may be influenced by a selection bias in favor of hearing loss, 
our overall 52.2% prevalence of hearing loss in OI largely agrees with those stated in other population 
studies
5-7, 11, 30
 and family studies
8, 9, 31-35
 investigating hearing in OI. However, the prevalence of 
hearing impairment in the OI population strongly depends on age. In the age range younger than 30 
years, less than half of the patients demonstrate hearing loss, whereas 75% of the OI patients in the 
age range 30 to 39 years are hearing-impaired. In subsequent decades, little increase in the 
prevalence of hearing loss is expected. The risk that a patient with OI, demonstrating normal hearing 
at age 40 years, will develop hearing loss in the course of the following decades is very small. 
Nevertheless, in the hearing-impaired patients the thresholds progress to a more severe hearing loss. 
An association between increasing age and a growing proportion of hearing impairment in the OI 
population was already established by Riedner et al.
8
, Pedersen
5
, Stewart & O’Reilly
7
 and Garretsen 
et al.
10
 However, these studies report a continuing increase in the proportion of hearing-impaired 
patients after the fourth decade, attaining almost 100% in the age group above 60 years
5, 8, 10
. Except 
for the study by Pedersen
5
, the sample size of OI patients in the older age groups were smaller in 
comparison with the present study. In addition, it is not clear whether the physiological age-related 
decline in hearing thresholds was taken into consideration in the studies by Riedner et al.
8
, Pedersen
5
 
and Stewart & O’Reilly
7
. These methodological discrepancies possibly have led to overestimation of 
the hearing loss prevalence in the older OI population by previous studies. 
More agreement between the present and earlier studies exists with regard to the type and onset of 
hearing deterioration in OI. Usually, a mild conductive hearing loss arises in the second to fourth 
decades of life and progresses to a moderate-to-severe mixed hearing loss in the following decades. 
In a few cases it will end up in profound hearing loss or deafness.
5-10, 12
 Stapes footplate fixation is the 
most common cause for the OI-related conductive hearing loss and may be solved by stapes surgery. 
Though, compared to otosclerosis, such an intervention is more challenging in OI because of a higher 
risk on complications, such as extremely thick and hard, overgrown or brittle footplates, bleeding 
tendency of the highly vascularized middle ear mucosa and ossicular atrophy or fractures
13-17
. 
Therefore, differential diagnosis between both diseases is important. Subtle differences in the 
 
 
audiometric patterns may assist in distuinguishing OI-related hearing loss from otosclerosis. Our 
ARTAs for OI patients with conductive/mixed hearing loss reflect progression of both the AC and BC 
thresholds, while the ABG remains relatively stable. Consequently, in OI, the hearing deterioration is 
mainly determined by progression of the sensorineural component, whereas otosclerosis is 
characterized by a progressive ABG but rarely by such a progressive sensorineural component. The 
ABG in OI appears to be age-independent, but frequency-specific as it is more prominent at the lower 
octave frequencies (≤1.0 kHz). The more severe hearing loss progression in OI and the more 
extensive inner ear involvement might be attributed to the overall inferior bone quality inherent to the 
disease, which renders the otic capsule more susceptible to become occupied by the continuing 
abnormal bone remodeling process that initially only affects the stapes footplate. Furthermore, in 
comparison with otosclerosis, the conductive hearing loss in OI has a relatively early onset, most often 
situated at the end of the second or the beginning of the third decade, whereas Nager
36
 reported a 
mean age of 33 years for the development of otosclerosis. Finally, the OI-related conductive/mixed 
hearing loss is not characterized by a preponderance of female over male patients as is found in 
otosclerosis.  
Shapiro et al.
34
 introduced a mild high-frequency pure sensorineural hearing loss as the characteristic 
hearing loss in OI, affecting approximately 47% of OI patients. On the other hand, this so-called 
characteristic high-frequency sensorineural loss was observed only sporadically in other OI 
populations
5, 10, 12
, as well as in ours, yielding a 1.4% prevalence of this isolated high-frequency pure 
sensorineural loss. More often, we observed a pure sensorineural loss involving the lower frequencies 
as well, affecting OI patients from all age categories, which is concordant with the findings of other 
large population studies
5-7, 10
. Compared with the above-described conductive/mixed hearing loss, this 
pure sensorineural loss in OI seems to be characterized by a slower progression with less severely 
affected thresholds. Separate ARTAs are constructed for OI patients developing this type of hearing 
loss, which confirm Pedersen’s
5
 impression that pure sensorineural hearing loss in OI parallels the 
normal physiologic deterioration in hearing ability with advancing age; however, the deterioration runs 
ahead in time. The ATD is smaller than 0.1 dB/year at octave frequencies below 1.0 kHz, but attains 
1.0 and 1.2 dB/year at 4.0 and 8.0 kHz, respectively. Conspicuously, the ARTAs for female OI patients 
in their first 3 decades reflect low-frequent pure sensorineural loss, whereas thresholds at 4.0 and 8.0 
kHz are within the 95
th
 percentile of gender- and age-related thresholds in the healthy population. 
  
Misdiagnosis of an initiating conductive loss as pure sensorineural hearing loss because of an initially 
subtle ABG but abnormally elevated average AC thresholds may probably explain this unexpected 
audiometric pattern of low-frequent sensorineural hearing loss in the young female OI population. 
Even admittance or stapedius reflex measurements cannot adequately identify a conductive 
component in the ears of OI patients. These audiologic tests have been assumed to be valuable for 
identification of middle ear pathologies and for differentiation between ossicular discontinuity and 
stapes fixation
37
, two conditions that may contribute to hearing loss in OI. However, the translucent 
and hypermobile eardrums, typical for OI ears, apparently have a masking effect on the high and low 
admittance pathologies in the middle ear. Even when a high probe-tone is used, it remains difficult to 
interpret the results in light of the audiometric thresholds. Consequently, normal admittance and 
abnormally high or low admittance are recorded without any reference to the presence or type of 
hearing loss determined by pure-tone audiometry, which is consistent with earlier studies
7-9, 32, 34
. 
Biphasic acoustic reflexes, as an indicator of early stapes fixation were observed in OI ears by Riedner 
et al.
8
 and Pedersen
5
, but not in the present study, neither in those by Carruth et al.
32
 and Cox & 
Simmons
9
. Furthermore, acoustic reflexes in OI patients with normal hearing thresholds may be 
absent, which also was noted in other studies with OI patients
5, 9, 12, 34
. Their absence might be an 
indicator of early stapedial fixation and a motivation for regular follow-up. Therefore, it is 
recommended to record ASRs in all OI patients and to bear in mind the risk of an initiating conductive 
loss in those patients with absent reflexes but normal audiograms.   
Comparing the ARTAs for conductive/mixed hearing loss with those for pure sensorineural loss in OI 
yields differences in progression, severity, and audiometric configuration between both hearing loss 
types. The age-related BC thresholds of the mixed hearing loss type exceed the thresholds of the pure 
sensorineural losses from 40 years onwards, implying a more destructive inner ear pathology in the OI 
patients with mixed hearing loss compared with those with pure sensorineural loss. Consistent with 
other research
5, 34
 we obtained well-preserved SRTs in OI-related hearing loss despite the relatively 
high prevalence of a sensorineural component. However, discrepancies between the audiometric AC 
thresholds and the SRT were observed more often in the OI patients with conductive/mixed than in 
those with pure sensorineural loss. In the OI patients demonstrating mixed hearing loss, the 
sensorineural component is most likely due to involvement of inner ear structures and pericochlear 
bone in the pathological bone remodeling process, whereas it initially only affects the stapes footplate 
 
 
and causes a pure conductive hearing loss. More uncertainty remains about the pathophysiology of 
the pure sensorineural hearing loss in OI. It has been attributed to retrocochlear otosclerosis-like 
pathology, to hair cell atrophy, atrophy of the stria vascularis and microfractures of the cochlea. The 
presently depicted differences in audiologic characteristics assume a different underlying 
pathophysiology for both types of hearing loss in OI. 
 
5. Conclusion 
In the OI population, the prevalence of hearing loss is markedly elevated compared to the healthy 
population. Most often, a conductive hearing loss arises in the second to fourth decades of life and, 
thereafter, evolves to a mixed hearing loss characterized by an ATD of approximately 0.5 dB/year at 
low and mid-freqencies and 0.8 dB/year at the highest octave frequencies. After the age of 40 years, 
the risk to develop a hearing loss in OI is apparently reduced. However, a minority of OI patients 
develop a pure sensorineural hearing loss, which may initiate at any age. The latter hearing loss type 
is, in general, less progressive and less severe than the OI-related conductive or mixed hearing loss. 
Age-related typical audiograms for both types of hearing loss are established and may help the 
clinician to predict the course of the hearing loss in patients with OI. In addition, they may useful in the 
differential diagnosis between OI and otosclerosis, which is important when stapes surgery is 
considered. Regular follow-up of hearing in OI patients is recommended from a young age onwards, 
because the hearing loss often develops at school age and may severely interfere with learning skills 
when it remains undiagnosed. 
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